FDA Approves New Method to Stop Overdose


Yesterday the FDA announced that they have approved Narcan nasal spray. A new version of naloxone that, unlike the most common versions currently being used, does not require a needle or any assembly prior to administering it. This means those suffering an opioid overdose, such as from prescription painkillers or heroin, can get this life-saving medication as fast as possible - and should take effect in about two minutes.

Excerpt from the FDA release:

“Combating the opioid abuse epidemic is a top priority for the FDA,” said Stephen Ostroff, M.D., acting commissioner, Food and Drug Administration. “We cannot stand by while Americans are dying. While naloxone will not solve the underlying problems of the opioid epidemic, we are speeding to review new formulations that will ultimately save lives that might otherwise be lost to drug addiction and overdose.”

Until this approval, naloxone was only approved in injectable forms, most commonly delivered by syringe or auto-injector. Many first responders and primary caregivers, however, feel a nasal spray formulation of naloxone is easier to deliver, and eliminates the risk of a contaminated needle stick.

Read the full release here.

Inquiries:
Media

Eric Pahon 240-402-4177

Consumers

888-INFO-FDA


Featured Posts
Recent Posts
Search By Tags
No tags yet.
Follow Us
  • Facebook Classic
  • Twitter Classic
  • Google Classic

​​Call us:

703-662-6076

for TTP/TTY dial 771

Mailing Address:

P.O. Box 9282, Reston, VA 20195

© 2016-2018 by The Chris Atwood Foundation